BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang H, Zhong JT, Zhou SH, Han HM. Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer. Oncotarget 2019;10:3066-83. [PMID: 31105886 DOI: 10.18632/oncotarget.24684] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Xin K, Hu B, Han L, Yu Q. Study on the HIF-1α regulated by glycolytic pathways and mitochondrial function in yaks of different altitudes during postmortem aging. J Food Biochem 2022;:e14205. [PMID: 35502450 DOI: 10.1111/jfbc.14205] [Reference Citation Analysis]
2 Pi M, Kuang H, Yue C, Yang Q, Wu A, Li Y, Assaraf YG, Yang D, Wu S. Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma. Drug Resistance Updates 2022;61:100822. [DOI: 10.1016/j.drup.2022.100822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Ibrahiem AT, Fawzy MS, Abdulhakim JA, Toraih EA. GLUT1 and ASCT2 Protein Expression in Papillary Thyroid Carcinoma Patients and Relation to Hepatitis C Virus: A Propensity-Score Matched Analysis. IJGM 2022;Volume 15:2929-44. [DOI: 10.2147/ijgm.s354108] [Reference Citation Analysis]
4 Kleszcz R, Paluszczak J. The Wnt Signaling Pathway Inhibitors Improve the Therapeutic Activity of Glycolysis Modulators against Tongue Cancer Cells. Int J Mol Sci 2022;23:1248. [PMID: 35163171 DOI: 10.3390/ijms23031248] [Reference Citation Analysis]
5 Bao L, Xu T, Lu X, Huang P, Pan Z, Ge M. Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment. Front Oncol 2021;11:773028. [PMID: 34926283 DOI: 10.3389/fonc.2021.773028] [Reference Citation Analysis]
6 Zeng X, Li Z, Zhu C, Xu L, Sun Y, Han S. Research progress of nanocarriers for gene therapy targeting abnormal glucose and lipid metabolism in tumors. Drug Deliv 2021;28:2329-47. [PMID: 34730054 DOI: 10.1080/10717544.2021.1995081] [Reference Citation Analysis]
7 Padda J, Khalid K, Kakani V, Cooper AC, Jean-Charles G. Metabolic Acidosis in Leukemia. Cureus 2021;13:e17732. [PMID: 34659946 DOI: 10.7759/cureus.17732] [Reference Citation Analysis]
8 Reyes Marlés RH, Navarro Fernández JL, Puertas García-Sandoval JP, Santonja Medina F, Mohamed Salem L, Frutos Esteban L, Contreras Gutiérrez JF, Castellón Sánchez MI, Ruiz Merino G, Claver Valderas MA. Clinical value of baseline 18F-FDG PET/CT in soft tissue sarcomas. Eur J Hybrid Imaging 2021;5:16. [PMID: 34476632 DOI: 10.1186/s41824-021-00110-5] [Reference Citation Analysis]
9 Pliszka M, Szablewski L. Glucose Transporters as a Target for Anticancer Therapy. Cancers (Basel) 2021;13:4184. [PMID: 34439338 DOI: 10.3390/cancers13164184] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Onizuka H, Masui K, Amano K, Kawamata T, Yamamoto T, Nagashima Y, Shibata N. Metabolic Reprogramming Drives Pituitary Tumor Growth through Epigenetic Regulation of TERT. Acta Histochem Cytochem 2021;54:87-96. [PMID: 34276102 DOI: 10.1267/ahc.21-00007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Echeverría C, Nualart F, Ferrada L, Smith GJ, Godoy AS. Hexose Transporters in Cancer: From Multifunctionality to Diagnosis and Therapy. Trends in Endocrinology & Metabolism 2021;32:198-211. [DOI: 10.1016/j.tem.2020.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
12 Mukada N, Tosaka M, Matsumura N, Yamaguchi R, Aihara M, Isoda K, Higuchi T, Tsushima Y, Yokoo H, Yoshimoto Y. Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study. Sci Rep 2021;11:126. [PMID: 33420213 DOI: 10.1038/s41598-020-80259-4] [Reference Citation Analysis]
13 Yang J, Wu Z, Chen Y, Hu C, Li D, Chen Y, Imani S, Wen Q, Fu S, Wu J. Pre-treatment with Bifidobacterium infantis and its specific antibodies enhance targeted radiosensitization in a murine model for lung cancer. J Cancer Res Clin Oncol 2021;147:411-22. [PMID: 33130941 DOI: 10.1007/s00432-020-03434-0] [Reference Citation Analysis]
14 Sampedro-Núñez M, Bouthelier A, Serrano-Somavilla A, Martínez-Hernández R, Adrados M, Martín-Pérez E, Muñoz de Nova JL, Cameselle-Teijeiro JM, Blanco-Carrera C, Cabezas-Agricola JM, Díaz JÁ, García-Centeno R, Aragones J, Marazuela M. LAT-1 and GLUT-1 Carrier Expression and Its Prognostic Value in Gastroenteropancreatic Neuroendocrine Tumors. Cancers (Basel) 2020;12:E2968. [PMID: 33066332 DOI: 10.3390/cancers12102968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Achalandabaso Boira M, Di Martino M, Gordillo C, Adrados M, Martín-Pérez E. GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival. BMC Cancer 2020;20:909. [PMID: 32967636 DOI: 10.1186/s12885-020-07409-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chandel V, Raj S, Kumar P, Gupta S, Dhasmana A, Kesari KK, Ruokolainen J, Mehra P, Das BC, Kamal MA, Kumar D. Metabolic regulation in HPV associated head and neck squamous cell carcinoma. Life Sci 2020;258:118236. [PMID: 32795537 DOI: 10.1016/j.lfs.2020.118236] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Heydarzadeh S, Moshtaghie AA, Daneshpoor M, Hedayati M. Regulators of glucose uptake in thyroid cancer cell lines. Cell Commun Signal. 2020;18:83. [PMID: 32493394 DOI: 10.1186/s12964-020-00586-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
18 Al-Azzam N. Sirtuin 6 and metabolic genes interplay in Warburg effect in cancers. J Clin Biochem Nutr 2020;66:169-75. [PMID: 32523242 DOI: 10.3164/jcbn.19-110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Brahmbhatt AN, Skalski KA, Bhatt AA. Vascular lesions of the head and neck: an update on classification and imaging review. Insights Imaging 2020;11:19. [PMID: 32034537 DOI: 10.1186/s13244-019-0818-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
20 Wang X, Wang H, Zhang T, Cai L, Dai E, He J. Diabetes and its Potential Impact on Head and Neck Oncogenesis. J Cancer 2020;11:583-91. [PMID: 31942181 DOI: 10.7150/jca.35607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Bakht MK, Lovnicki JM, Tubman J, Stringer KF, Chiaramonte J, Reynolds MR, Derecichei I, Ferraiuolo RM, Fifield BA, Lubanska D, Oh SW, Cheon GJ, Kwak C, Jeong CW, Kang KW, Trant JF, Morrissey C, Coleman IM, Wang Y, Ahmadzadehfar H, Dong X, Porter LA. Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors. J Nucl Med 2020;61:904-10. [PMID: 31806771 DOI: 10.2967/jnumed.119.231068] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
22 Voropaev H, Gimmelshein Vatkin M, Shneor D, Luski S, Honigman A, Frenkel S. Infectious Knockdown of CREB and HIF-1 for the Treatment of Metastatic Uveal Melanoma. Cancers (Basel) 2019;11:E1056. [PMID: 31357444 DOI: 10.3390/cancers11081056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]